Principal Financial Group Inc Xeris Biopharma Holdings, Inc. Transaction History
Principal Financial Group Inc
- $184 Billion
- Q3 2025
A detailed history of Principal Financial Group Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 105,493 shares of XERS stock, worth $764,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,493
Previous 153,937
31.47%
Holding current value
$764,824
Previous $718,000
18.94%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...